Y. Seo et al. / Tetrahedron: Asymmetry 25 (2014) 625–631
629
4.4.1. 3-tert-Butyl 5-methyl (4S,5R)-4-isobutyloxazoline-3,5-
4.5.1.2. tert-Butyl (4S,5R)-4-isobutyl-5-(nitromethyl)oxazoli-
dicarboxylate 3b
dine-3-carboxylate 4b. 72% (50 mg); colorless oil; ½a D14
¼ ꢀ8:2
ꢂ
69% (54 mg); colorless oil; ½a D16
ꢂ
¼ ꢀ6:7 (c 0.34, CHCl3); 1H NMR
(c 0.26, CHCl3); 1H NMR (50 °C)28 d 0.98 (d, 3H, J = 6.4), 1.02
(d, 3H, J = 6.4), 1.43–1.51 (m, 1H), 1.51 (s, 9H), 1.61–1.71 (m,
2H), 3.98 (t, 1H, J = 6.4), 4.39–4.51 (m, 3H), 4.74 (d, 1H, J = 4.8),
5.20 (d, 1H, J = 4.8); 13C NMR d 22.5, 23.0, 25.2, 28.5, 42.2, 56.9,
(50 °C)28 d 0.99 (d, 3H, J = 6.8), 1.01 (d, 3H, J = 6.4), 1.43–1.48 (m,
1H), 1.48 (s, 9H), 1.58–1.65 (m, 1H), 1.68–1.73 (m, 1H), 3.77 (s,
3H), 4.24 (t, 1H, J = 6.6), 4.34 (s, 1H), 4.82 (d, 1H, J = 3.6), 5.28 (d,
1H, J = 3.6); 13C NMR d 22.2, 23.0, 25.3, 28.4, 42.3, 52.4, 57.9,
76.8, 78.2, 79.1, 81.3, 153.2; IR (film): 1372, 1559, 1704 cmꢀ1
HRMS (CI) calcd for
289.1760.
;
79.1, 79.1, 80.8, 152.9, 171.5; IR (film): 1169, 1702, 1755 cmꢀ1
;
C
13H25N2O5 289.1763 ([M+H]+), found
HRMS (CI) calcd for
288.1808.
C
14H26NO5 288.1811 ([M+H]+), found
4.5.2. Two-step procedure for 3a from 4a
Nitromethyloxazolidine 4a (R = Bn, 73 mg, 0.23 mmol) in t-
BuOH (2 mL) was stirred in an aqueous solution of 0.5 M KOH buf-
fered with 1.25 M of K2HPO4 (1.5 mL) at room temperature for
5 min. To the reaction mixture an aqueous solution of 0.5 M
KMnO4 (0.90 mL) was slowly added at 0 °C and then stirred at
room temperature for 1 h. The reaction was quenched with an
aqueous saturated solution of Na2SO3 (5 mL) at 0 °C, and the reac-
tion mixture was acidified with an aqueous solution of 1 M HCl
(6 mL). The resulting mixture was separated, and the aqueous layer
was extracted with EtOAc (10 mL ꢁ 3). The combined organic lay-
ers were dried over MgSO4, filtered, and concentrated under re-
duced pressure to afford the corresponding acid intermediate 5a.
To crude acid 5a in DMF (2 mL) was added K2CO3 (94 mg,
0.68 mmol) and MeI (0.03 mL, 0.45 mmol). After 1 h at room tem-
perature, the mixture was poured into cold water (10 mL). The
resulting mixture was extracted with diethyl ether (10 mL ꢁ 3).
The combined organic layers were dried over MgSO4, filtered,
and concentrated under reduced pressure. The organic residue
was purified by silica gel chromatography (hexane/EtOAc = 8:1)
to afford the desired ester 3a (51 mg, 70%) as a colorless oil.
4.4.2. 3-tert-Butyl 5-methyl (4S,5R)-4-isopropyloxazolidine-3,5-
dicarboxylate 3c
65% (109 mg), colorless oil; ½a D17
ꢂ
¼ ꢀ10:7 (c 1.17, CHCl3); 1H
NMR (50 °C)28 d 0.89 (d, 3H, J = 6.4), 0.90 (d, 3H, J = 6.4), 1.39 (s,
9H), 1.89–1.98 (m, 1H), 3.67 (s, 3H), 3.89 (d, 1H, J = 5.2), 4.36 (s,
1H), 4.72 (d, 1H, J = 3.2), 5.19 (br s, 1H); 13C NMR d 18.0, 18.8,
28.3, 31.0, 52.3, 64.6, 76.8, 80.0, 80.6, 153.3, 171.8; IR (film):
1173, 1711, 1757 cmꢀ1; HRMS (CI) calcd for C13H24NO5 274.1654
([M+H]+), found 274.1658.
4.4.3. 3-tert-Butyl 5-methyl (4S,5R)-4-methyloxazolidine-3,5-
dicarboxylate 3d
67% (81 mg), colorless oil; ½a D15
ꢂ
¼ ꢀ5:9 (c 0.44, CHCl3); 1H NMR
(50 °C)28 d 1.37 (d, 3H, J = 6.4), 1.46 (s, 9H), 3.77 (s, 3H), 4.14 (br s,
1H), 4.24 (d, 1H, J = 3.2), 4.84 (d, 1H, J = 3.8), 5.20 (d, 1H, J = 3.8); 13
C
NMR d 19.3, 28.5, 52.6, 55.0, 79.2, 80.8, 81.9, 152.6, 170.9; IR (film):
1175, 1707, 1756 cmꢀ1; HRMS (CI) calcd for C11H20NO5 246.1341
([M+H]+), found 246.1345.
4.4.4. 3-tert-Butyl 5-methyl (4S,5R)-4-((tert-butyldimethylsilyl-
oxy)methyl)oxazolidine-3,5-dicarboxylate 3e
79% (93 mg), colorless oil; ½a D15
ꢂ
¼ ꢀ10:5 (c 0.71, CHCl3); 1H NMR
4.6. General procedure for b-amino-
or AHMHAꢃHCl, from 3a and 3b
a
-hydroxy acids, AHPBAꢃHCl
(50 °C)28 d 0.06 (s, 3H), 0.07 (s, 3H), 0.90 (s, 9H), 1.46 (s, 9H), 3.72–
3.81 (m, 2H), 3.77 (s, 3H), 4.07 (br s, 1H), 4.71 (d, 1H, J = 3.6), 4.79
(d, 1H, J = 3.2), 5.19 (br s, 1H); 13C NMR d ꢀ5.3, 18.2, 25.9, 28.5,
52.5, 60.2, 61.7, 77.9, 80.1, 80.9, 152.5, 171.3; IR (film): 839,
Methyl ester 3a (R = Bn, 152 mg, 0.47 mmol) in an aqueous
solution of 3 M HCl (8 mL) was heated at 80 °C for 8 h. After cooling
back to room temperature, the resulting mixture was washed with
CH2Cl2 (20 mL ꢁ 2) and EtOAc (20 mL ꢁ 2). The aqueous layer was
concentrated under reduced pressure to give the AHPBAꢃHCl salt.
1175, 1709, 1752 cmꢀ1
; HRMS (CI) calcd for C17H34NO6Si
376.2155 ([M+H]+), found 376.2159.
4.5. Stepwise procedure for methyl ester 3
4.6.1. (2R,3S)-3-Amino-2-hydroxy-4-phenylbutanoic acid hydro-
chloride AHPBAꢃHCl (R = Bn)
4.5.1. General procedure for nitromethyloxazolidine 4a or 4b
To conjugate adduct 2a (R = Bn, 67 mg, 0.15 mmol) in toluene
(2 mL) were added N-benzylnicotinamide (BNAH, 93 mg,
0.44 mmol) and AIBN (5 mg, 0.03 mmol). The reaction mixture
was reacted at 60 °C for 1 h in a microwave (MW) reactor
(15 W). Next, the mixture was diluted with EtOAc (2 mL), to which
was added H2O (5 mL). The organic layer was separated and the
aqueous layer was extracted with EtOAc (10 mL ꢁ 3). The com-
bined organic layers were dried over MgSO4, filtered, and concen-
trated under reduced pressure. The organic residue was purified by
silica gel chromatography (hexane/EtOAc = 8:1) to afford nitrom-
ethyloxazolidine 4a.
92% (85 mg); white solid; mp 206–208 °C (lit21a; 209–210 °C);
½
a 2D6
ꢂ
¼ ꢀ28:8 (c 1.68, 1 M HCl); (lit.21b
[a]D = +29.3 (c 0.43, 1 M
HCl); 1H NMR (DMSO-d6) d 2.88 (dd, 1H, J = 9.6, 13.4), 3.03 (dd,
1H, J = 5.2, 13.4), 3.58–3.60 (m, 1H), 3.89 (d, 1H, J = 2.4), 7.27–
7.36 (m, 5H), 8.18 (br s, 1H); 13C NMR d 35.1, 53.9, 67.4, 126.9,
128.6, 129.3, 136.2, 172.7; IR (film); 1072, 1730, 2931,
3040 cmꢀ1; HRMS (CI) calcd for C10H14NO3 196.0974 ([M+H]+),
found 196.0971.
4.6.2. (2R,3S)-3-Amino-2-hydroxy-5-methylhexanoic acid hydro-
chloride AHMHAꢃHCl (R = i-Bu)
88% (93 mg); white solid; mp 208–210 °C (lit.24a 188–189 °C,
lit.24b 228–229 °C) 1H NMR (MeOH-d4) d 0.98 (d, 3H, J = 6.4), 1.00
(d, 3H, J = 6.4), 1.47–1.54 (m, 1H), 1.64–1.79 (m, 2H), 3.56 (dt,
1H, J = 3.2, 7.0), 4.23 (d, 1H, J = 3.2); 13C NMR d 22.5, 22.7, 25.4,
4.5.1.1. tert-Butyl (4S,5R)-4-benzyl-5-(nitromethyl)oxazolidine-
3-carboxylate 4a. 62% (29 mg); colorless oil; ½a D15
¼ ꢀ5:7 (c 2.53,
ꢂ
CHCl3); 1H NMR (50 °C)28 d 1.51 (s, 9H), 2.82 (dd, 1H, J = 9.2, 12.0),
3.26 (br d, 1H, J = 12.0), 3.95–4.01 (m, 2H), 4.32 (dd, 1H, J = 8.4,
12.8), 4.58–4.63 (m, 1H), 4.69 (d, 1H, J = 4.0), 5.17 (br s, 1H),
7.23–7.37 (m, 5H); 13C NMR d 28.4, 38.7, 59.2, 76.5, 78.6, 78.8,
81.4, 127.4, 129.1, 129.4, 136.4, 152.8; IR (film): 1370, 1557,
1679 cmꢀ1; HRMS (CI) calcd for C16H23N2O5 323.1607 ([M+H]+),
found 323.1611.
39.8, 52.8, 70.4, 174.4; IR (film): 1101, 1657, 2960, 3367 cmꢀ1
;
HRMS (CI) calcd for C7H16NO3 162.1130 ([M+H]+), found
162.1131. The free amino acid form of (2R,3S)-AHMHA was ob-
tained in quantitative yield by treating (2R,3S)-AHMHAꢃHCl with
a Dowex resin (50WX8); ½a D28
ꢂ
¼ þ25:0 (c 1.28, AcOH), (lit.24b
½
a 2D5
ꢂ
¼ þ25:2 (c 0.6, AcOH)).